What data powers the Rallies AI report for EXOZ?

Rallies AI research for EXOZ combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.

Is EXOZ research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.

EXOZ (eXoZymes Inc. Common Stock) Stock Analysis - AI Report

eXoZymes Inc. Common Stock (EXOZ) is a publicly traded Healthcare sector company. As of May 21, 2026, EXOZ trades at $9.40 with a market cap of $80.97M and a P/E ratio of -8.83. EXOZ moved -2.11% today. Year to date, EXOZ is -15.50%; over the trailing twelve months it is -10.22%. Its 52-week range spans $7.08 to $23.99. Rallies surfaces EXOZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on EXOZ?

Rallies AI research for EXOZ combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

EXOZ Key Metrics

Key financial metrics for EXOZ
Metric	Value
Price	$9.40
Market Cap	$80.97M
P/E Ratio	-8.83
EPS	$-1.09
Dividend Yield	0.00%
52-Week High	$23.99
52-Week Low	$7.08
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-9.16M
Gross Margin	0.00%

Latest EXOZ News

eXoZymes Graduates Shell GameChanger Program, Gains Multimillion-Dollar Support to Scale Platform — May 7, 2026
eXoZymes NCTx Spinout Validates 100-Fold Scale-Up with 99.6% Purity — Apr 10, 2026
EXoZymes Raises April Fundraising to Back NCT and Cannabinoid Scale-Up — Apr 1, 2026
eXoZymes Posts $9.16M Net Loss, $9.72M Expenses and $3.04M Cash; Files S-3 — Mar 31, 2026
eXoZymes Pilot Run Yields 500g NCT at 99.6% Purity on 100L Scale — Mar 18, 2026

Recent EXOZ Insider Trades

Korman Tyler Paz sold 750 (~$7.89K) on Apr 9, 2026.
Korman Tyler Paz sold 750 (~$7.53K) on Apr 8, 2026.
Heltzen Michael bought 1.04K (~$10.63K) on Jul 2, 2025.

EXOZ Analyst Consensus

EXOZ analyst coverage data. Average price target: $0.00.

Common questions about EXOZ

What is the AI research view on EXOZ?: Rallies AI research for EXOZ combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for EXOZ?: Rallies AI research for EXOZ combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is EXOZ research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.